Efficacy of a dentifrice for dentine hypersensitivity containing 5.6% potassium citrate and 0.3% sodium fluoride: a randomized clinical controlled trial
DOI:
https://doi.org/10.17533/udea.rfo.2503Keywords:
Dentin hypersensitivity, Dentin sensitivity, Potassium citrate, Sodium fluorideAbstract
Introduction: potassium and fluoride salts have been used for the treatment of dentine hypersensitivity. The objective of this study was to determine the efficacy of a tooth paste with 5.6% of potassium citrate and 0.3% of sodium fluoride for the treatment of dentine hypersensitivity. Methods: a randomized sample of 100 people, male and female from the Valle de Aburrá, older than 18 years of age, with dentine hypersensitivity and who met the inclusion criteria was selected. A randomized triple blind clinical trial was designed, using a control group (placebo), and an experimental group (tooth paste for sensitive teeth). The subjects were given a questionnaire in which they rated the intensity of the pain using the visual analogical scale before the intervention; next, a tooth was selected in each person and subjected to a thermal stimulus test and constant pressure contact test, also rating the intensity of the pain in each test using the visual analogical pain scale. Each subject received a soft toothbrush and the product containing the active principle or the placebo was supplied to them at random. The patients were evaluated and subjected to the same tests used at the beginning of the study, at the fourth week and at the eight week, registering the data obtained for each of the tests during the three evaluation periods. None of the participants, that is, neither the doctor, nor the patient nor the statistician knew which toothpaste (active component or placebo) was supplied to the patients. Results: the results showed that there was a decrease in hypersensitivity in both groups; however, the sensitivity toothpaste showed a greater decrease in all the measurements with the different tests applied. Conclusions: although there was a decrease in the symptoms of the placebo group, there was a statistically significant larger decrease in the group that used the sensitivity toothpaste.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright Notice
Copyright comprises moral and patrimonial rights.
1. Moral rights: are born at the moment of the creation of the work, without the need to register it. They belong to the author in a personal and unrelinquishable manner; also, they are imprescriptible, unalienable and non negotiable. Moral rights are the right to paternity of the work, the right to integrity of the work, the right to maintain the work unedited or to publish it under a pseudonym or anonymously, the right to modify the work, the right to repent and, the right to be mentioned, in accordance with the definitions established in article 40 of Intellectual property bylaws of the Universidad (RECTORAL RESOLUTION 21231 of 2005).
2. Patrimonial rights: they consist of the capacity of financially dispose and benefit from the work trough any mean. Also, the patrimonial rights are relinquishable, attachable, prescriptive, temporary and transmissible, and they are caused with the publication or divulgation of the work. To the effect of publication of articles in the journal Revista de la Facultad de Odontología, it is understood that Universidad de Antioquia is the owner of the patrimonial rights of the contents of the publication.
The content of the publications is the exclusive responsibility of the authors. Neither the printing press, nor the editors, nor the Editorial Board will be responsible for the use of the information contained in the articles.
I, we, the author(s), and through me (us), the Entity for which I, am (are) working, hereby transfer in a total and definitive manner and without any limitation, to the Revista Facultad de Odontología Universidad de Antioquia, the patrimonial rights corresponding to the article presented for physical and digital publication. I also declare that neither this article, nor part of it has been published in another journal.
Open Access Policy
The articles published in our Journal are fully open access, as we consider that providing the public with free access to research contributes to a greater global exchange of knowledge.
Creative Commons License
The Journal offers its content to third parties without any kind of economic compensation or embargo on the articles. Articles are published under the terms of a Creative Commons license, known as Attribution – NonCommercial – Share Alike (BY-NC-SA), which permits use, distribution and reproduction in any medium, provided that the original work is properly cited and that the new productions are licensed under the same conditions.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
